•  
  •  
  •  
  •  

2026-07-31 11:46:09

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • SEDEMAC Mechatronics Reports Q1 FY27 Results: Net Profit Surges 95.1% YoY to ₹33.31 Crore
  • Unified Data Tech Solutions Ltd - Q1FY27 Business Update
  • IRIS RegTech Solutions Bagging Contract Extension for South Africa's CODI Deposit Insurance Project
  • Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
  • RPG Life Sciences Reports Q1 FY27 Results: Consolidated Net Profit Up 17% YoY to ₹30.76 Crore

Keywords Selected:  SANDUPHARMACEUTICALS

Stock Report

  • Sandu Pharmaceuticals Ltd recommends final dividend of Rs. 1
  • Sandu Pharmaceuticals Ltd Q4 FY2025-26 net profit at Rs. 4.34 lakhs
  • Sandu Pharmaceuticals Ltd Q2 FY2024 consolidated PAT at Rs. 55.06 lakhs
  • Sandu Pharmaceuticals Ltd announces temporary closure of Goa factory for Maintenance
  • Sandu Pharmaceuticals Ltd Q1FY24 consolidated net profit declines to Rs. 10.93 lakhs
  • GIPB cancels plot allotted to Sandu Pharmaceuticals Ltd
  • Sandu Pharmaceuticals Ltd enters into MoU with Vietnam firm
  • Sandu Pharmaceuticals Ltd converts warrants into equity shares
  • Sandu Pharmaceuticals Limited allots 8,89,667 Equity Shares
  • Sandu Pharmaceuticals Q3FY22 net profit at Rs. 44.88 lakhs
  • Sandu Pharmaceuticals receives in principle nod for land allotment in Goa

Latest Post

  • SEDEMAC Mechatronics Reports Q1 FY27 Results: Net Profit Surges 95.1% YoY to ₹33.31 Crore
  • Unified Data Tech Solutions Ltd - Q1FY27 Business Update
  • IRIS RegTech Solutions Bagging Contract Extension for South Africa's CODI Deposit Insurance Project
  • Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
  • RPG Life Sciences Reports Q1 FY27 Results: Consolidated Net Profit Up 17% YoY to ₹30.76 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025